Clinical trial
A Single-Blind Trial of Risperidone vs. Paroxetine for Treatment of Panic…
NCT00457106 · Beth Israel Medical Center, Other · Completed
Key facts
| NCT number | NCT00457106 |
|---|---|
| Title | A Single-Blind Trial of Risperidone vs. Paroxetine for Treatment of Panic Attacks |
| Official title | A Single-Blind Trial of Risperidone vs. Paroxetine for Treatment of Panic Attacks |
| Lead sponsor | Beth Israel Medical Center, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Major Depression With Panic Attacks, Panic Disorder |
| Intervention type | Drug |
| Interventions | Paroxetine, Risperidone |
| Enrollment | 90 |
| Start date | Jun 1, 2002 |
| Primary completion | Jun 1, 2003 |
| Completion | Jun 1, 2003 |
| First posted | Apr 5, 2007 |
| Last update posted | Dec 1, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: